Gateway Investment Advisers’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,500
Closed -$226K 819
2026
Q1
$226K Buy
2,500
+192
+8% +$17.6K ﹤0.01% 663
2025
Q4
$208K Sell
2,308
-1,641
-42% -$156K ﹤0.01% 575
2025
Q3
$389K Sell
3,949
-1,292
-25% -$128K ﹤0.01% 435
2025
Q2
$478K Sell
5,241
-37
-0.7% -$3.58K 0.01% 372
2025
Q1
$597K Sell
5,278
-855
-14% -$91.5K 0.01% 384
2024
Q4
$648K Buy
6,133
+3,980
+185% +$427K 0.01% 365
2024
Q3
$232K Sell
2,153
-79
-4% -$8.62K ﹤0.01% 484
2024
Q2
$242K Sell
2,232
-9
-0.4% -$1.06K ﹤0.01% 469
2024
Q1
$296K Buy
2,241
+59
+3% +$7.37K ﹤0.01% 445
2023
Q4
$266K Sell
2,182
-55
-2% -$6.14K ﹤0.01% 450
2023
Q3
$251K Sell
2,237
-90
-4% -$11.4K ﹤0.01% 452
2023
Q2
$339K Sell
2,327
-43
-2% -$5.84K ﹤0.01% 416
2023
Q1
$306K Buy
2,370
+13
+0.6% +$1.63K ﹤0.01% 441
2022
Q4
$301K Sell
2,357
-235
-9% -$27.3K ﹤0.01% 462
2022
Q3
$271K Sell
2,592
-121
-4% -$13.3K ﹤0.01% 461
2022
Q2
$285K Buy
2,713
+40
+1% +$4.75K ﹤0.01% 486
2022
Q1
$342K Buy
2,673
+794
+42% +$95.7K ﹤0.01% 475
2021
Q4
$232K Buy
+1,879
New +$246K ﹤0.01% 505
2021
Q2
Sell
-1,355
Closed -$211K 540
2021
Q1
$211K Sell
1,355
-52
-4% -$8.05K ﹤0.01% 519
2020
Q4
$210K Sell
1,407
-208
-13% -$29.4K ﹤0.01% 520
2020
Q3
$213K Buy
+1,615
New +$211K ﹤0.01% 499
2020
Q2
Sell
-2,081
Closed -$204K 538
2020
Q1
$204K Buy
2,081
+101
+5% +$13.2K ﹤0.01% 501
2019
Q4
$288K Sell
1,980
-182
-8% -$25.1K ﹤0.01% 496
2019
Q3
$288K Sell
2,162
-5,861
-73% -$757K ﹤0.01% 517
2019
Q2
$917K Sell
8,023
-621
-7% -$72.7K 0.01% 462
2019
Q1
$1.07M Sell
8,644
-462
-5% -$52.5K 0.01% 446
2018
Q4
$917K Sell
9,106
-303
-3% -$34.1K 0.01% 469
2018
Q3
$1.2M Sell
9,409
-59
-0.6% -$7.01K 0.01% 435
2018
Q2
$1.02M Sell
9,468
-1,413
-13% -$154K 0.01% 464
2018
Q1
$1.15M Sell
10,881
-774
-7% -$89.9K 0.01% 453
2017
Q4
$1.37M Sell
11,655
-1,068
-8% -$121K 0.01% 442
2017
Q3
$1.45M Sell
12,723
-293
-2% -$33.8K 0.01% 446
2017
Q2
$1.62M Sell
13,016
-181
-1% -$21.5K 0.01% 411
2017
Q1
$1.56M Sell
13,197
-1,330
-9% -$151K 0.01% 403
2016
Q4
$1.46M Sell
14,527
-90
-0.6% -$9.65K 0.01% 419
2016
Q3
$1.84M Buy
14,617
+28
+0.2% +$3.46K 0.02% 383
2016
Q2
$1.71M Sell
14,589
-39
-0.3% -$4.41K 0.01% 400
2016
Q1
$1.51M Sell
14,628
-5,722
-28% -$554K 0.01% 400
2015
Q4
$2.03M Sell
20,350
-8
-0% -$783 0.02% 397
2015
Q3
$1.86M Sell
20,358
-2,476
-11% -$248K 0.02% 399
2015
Q2
$2.42M Buy
22,834
+331
+1% +$36.6K 0.02% 382
2015
Q1
$2.57M Buy
22,503
+387
+2% +$44.2K 0.02% 373
2014
Q4
$2.44M Sell
22,116
-9,158
-29% -$965K 0.02% 384
2014
Q3
$3.05M Buy
31,274
+574
+2% +$56.5K 0.02% 357
2014
Q2
$3.1M Buy
30,700
+3,535
+13% +$345K 0.02% 355
2014
Q1
$2.49M Sell
27,165
-712
-3% -$65.6K 0.02% 370
2013
Q4
$2.52M Sell
27,877
-412
-1% -$35.7K 0.02% 368
2013
Q3
$2.26M Buy
28,289
+990
+4% +$77.9K 0.02% 371
2013
Q2
$1.99M Buy
+27,299
New +$2.04M 0.02% 373

Other funds holding ZBH

Gateway Investment Advisers's ZBH Position: Q2 2026 in Review

Gateway Investment Advisers sold out of Zimmer Biomet (ZBH) in Q2 2026, closing a stake of 2,500 shares — an estimated $226K sold.

Gateway Investment Advisers first reported a position in ZBH in Q2 2013 and held it in 49 quarters. The position peaked at $3.1M in Q2 2014. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Gateway Investment Advisers reported no remaining Zimmer Biomet position as of Q2 2026 after selling out during the quarter.
  • Gateway Investment Advisers sold 2,500 Zimmer Biomet shares in Q2 2026, an estimated $226K.
  • Gateway Investment Advisers first reported a position in Zimmer Biomet in Q2 2013 and held it in 49 quarters.
  • Gateway Investment Advisers's Zimmer Biomet position peaked at $3.1M in Q2 2014.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Gateway Investment Advisers's 13F filing for Q2 2026, filed 20 Jul 2026.